Mikael Dolsten - Dec 15, 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
President R&D
Signature
Susan E. Grant, by power of atty., for Mikael Dolsten
Stock symbol
PFE
Transactions as of
Dec 15, 2023
Transactions value $
$1,000,010
Form type
4
Date filed
12/19/2023, 04:37 PM
Previous filing
Mar 20, 2023
Next filing
Feb 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $1M +37.6K +75.06% $26.63 87.6K Dec 15, 2023 Common Stock 37.6K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Deferred Compensation Plan.
F3 The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.